Moderna
MRNA
#1630
Rank
A$16.05 B
Marketcap
$41.53
Share price
-2.41%
Change (1 day)
-73.32%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: A$16.05 Billion

As of April 2025 Moderna has a market cap of A$16.05 Billion. This makes Moderna the world's 1630th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025A$16.05 B-35.33%
2024A$24.82 B-55.39%
2023A$55.65 B-45.11%
2022A$101.40 B-28.61%
2021A$142.03 B164.2%
2020A$53.76 B471.83%
2019A$9.40 B31.92%
2018A$7.12 B

End of Day market cap according to different sources

On Apr 3rd, 2025 the market cap of Moderna was reported to be:

A$16.41 Billion
by Nasdaq info icon info icon
A$16.45 Billion
by CompaniesMarketCap info icon info icon
A$16.45 Billion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$0.18 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$340.38 B 2,019.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.37 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.46 B 214.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$345.79 B 2,053.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$2.42 B-84.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$610.79 B 3,703.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.92 B-69.33%๐Ÿ‡บ๐Ÿ‡ธ USA